Source comparison
Selank Amidate Administration Methods: Subcutaneous vs Intranasal Comparison
Before committing to a specific administration route, understand how bioavailability and protocol complexity differ across methods. Subcutaneous Injection 85–95% systemic absorption 45–90 minutes 18–24 hours Moderate. Requires reconstitution, sterile technique
This comparison does not assign a generated winner or score.
- Before committing to a specific administration route, understand how bioavailability and protocol complexity differ across methods.
- Subcutaneous Injection
- 85–95% systemic absorption
- 45–90 minutes
- 18–24 hours
- Moderate. Requires reconstitution, sterile technique, proper injection angle
- Highest consistency for cognitive enhancement protocols. Predictable plasma levels and sustained BDNF effects
- Intranasal Spray
- 40–60% systemic absorption (significant first-pass mucosal degradation)
- 15–30 minutes
- 8–12 hours
- Low. Pre-mixed solutions available, no injection required
- Faster onset but shorter duration. Suitable for acute anxiety management, less effective for sustained neuroplastic changes
- Oral Administration
- <10% (extensive GI peptide degradation)
- Not applicable
- N/A. Not viable for Selank
- Peptides are broken down by proteolytic enzymes before systemic absorption. Oral Selank is pharmacologically inert
- Subcutaneous remains the standard for research-grade cognitive enhancement protocols. The 18–24 hour effect window allows once-daily dosing, and the high bioavailability ensures dose consistency across multi-week cycles.